1. Home
  2. ICUI vs HAFN Comparison

ICUI vs HAFN Comparison

Compare ICUI & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • HAFN
  • Stock Information
  • Founded
  • ICUI 1984
  • HAFN 2012
  • Country
  • ICUI United States
  • HAFN Singapore
  • Employees
  • ICUI N/A
  • HAFN N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • HAFN
  • Sector
  • ICUI Health Care
  • HAFN
  • Exchange
  • ICUI Nasdaq
  • HAFN Nasdaq
  • Market Cap
  • ICUI 3.0B
  • HAFN 2.7B
  • IPO Year
  • ICUI 1992
  • HAFN N/A
  • Fundamental
  • Price
  • ICUI $129.10
  • HAFN $6.34
  • Analyst Decision
  • ICUI Buy
  • HAFN Strong Buy
  • Analyst Count
  • ICUI 6
  • HAFN 1
  • Target Price
  • ICUI $186.60
  • HAFN $6.50
  • AVG Volume (30 Days)
  • ICUI 269.3K
  • HAFN 1.3M
  • Earning Date
  • ICUI 11-11-2025
  • HAFN 08-27-2025
  • Dividend Yield
  • ICUI N/A
  • HAFN 9.90%
  • EPS Growth
  • ICUI N/A
  • HAFN N/A
  • EPS
  • ICUI N/A
  • HAFN 0.84
  • Revenue
  • ICUI $2,372,504,000.00
  • HAFN $2,354,657,000.00
  • Revenue This Year
  • ICUI N/A
  • HAFN N/A
  • Revenue Next Year
  • ICUI N/A
  • HAFN N/A
  • P/E Ratio
  • ICUI N/A
  • HAFN $7.55
  • Revenue Growth
  • ICUI 2.96
  • HAFN N/A
  • 52 Week Low
  • ICUI $107.00
  • HAFN $3.61
  • 52 Week High
  • ICUI $196.26
  • HAFN $7.84
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 51.94
  • HAFN 63.70
  • Support Level
  • ICUI $121.61
  • HAFN $5.98
  • Resistance Level
  • ICUI $136.61
  • HAFN $6.43
  • Average True Range (ATR)
  • ICUI 4.03
  • HAFN 0.14
  • MACD
  • ICUI 0.24
  • HAFN 0.00
  • Stochastic Oscillator
  • ICUI 49.93
  • HAFN 82.00

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About HAFN Hafnia Limited Common Shares

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

Share on Social Networks: